Proteomic analysis in human fibroblasts by continuous exposure to extremely low-frequency electromagnetic fields

Pakistan Journal of Biological Sciences

Volumn 10, Issue 22, 2007, Pages 4108-4112

  Seyyedi, Samaneh Sadat ^a   Dadras, Mohammad Shahidi ^b   Tavirani, Mostafa Rezaei ^c,d   Mozdarani, Hossein ^e   Toossi, Parviz ^b   Zali, Ali Reza ^b  

^a Khatam University   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Asre Novin Institute of Research and Industrial Services   (Iran)

^e TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Alpha 1 antitrypsin and transthyretin; ELF EMF; Human fibroblast cells

Indexed keywords

EID: 36349022019     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2007.4108.4112     Document Type: Article

References (34)

1. Aare, T., A.A. Dahl, J.B. Johansen, I. Kjonniksen and D. Neckelman, 2003. Efficacy of repetitive transcranial magnetic stimulation in depression: A review of the evidence. Nordic J. Psychiat., 57: 227-232.
2. 1-antitrypsin. Am. J. Hum. Genet., 17: 466-472.
3. Berman, R.M., M. Narasimhan, G. Sanacora, A.P. Miano, R.E. Hoffman, X.S. Hu, D.S. Charney and N.N. Boutros, 2000. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol. Psychiat., 47: 332-337.
4. Castaño, E.M., A.E. Roher, C.L. Esh, T.A. Kokjohn and T. Beach, 2006. Comparative proteomics of cerebrospinal fluid in neuropathologically- confirmed Alzheimer's disease and non-demented elderly subjects. Neurol Res. Mar., 28: 155-163.
5. DeMeo, D.L. and E.K. Silverman, 2004. α-antitrypsin deficiency. 2: Genetic aspects of α(1)-antitrypsin deficiency: Phenotypes and genetic modifiers of emphysema risk. Thorax, 59: 259-264.
6. El-Akawi, Z., M. Nusier and D.H. Sawalha, 2005. α-1-antitrypsin genotypes in breast cancer patients. Breast Cancer Res., 7: 1-19.
7. Gettins, P.G., 2002. Serpin structure, mechanism and function. Chem. Rev., 102: 4751-4804.
8. Gómez, M.J., L. Peña, J.M. Pastor, M. Martinez Morillo and L. Gil, 2000.25 Hz electromagnetic field exposure has no effect on cell cycle distribution and apoptosis in U-937 and HCA-2r1cch cells. Bioelectrochemistry, 53: 137-140.
9. Gottwald, E., W. Sontag, B. Lahni and K.F. Weibezahn, 2007. Expression of HSP72 after ELF-EMF exposure in three cell lines. Bioelectromagnetic, 16: (In Press).
10. Gu, J.R., H.Q. Jiang, L.P. He, D.Z. Li, X.M. Zhou, W.L. Dai, L.F. Qian, Y.Q. Chen, C. Schweinfest and T. Papas, 1991. Transthyretin (prealbumin) gene in human primary hepatic cancer. Sci. China B., 34: 1312-1318.
11. Hahn, G.M. and I. Van Kersen, 1988. Isolation and initial characterization of thermoresistant RIF tumor cell strains. Cancer Res., 48: 1803-1807.
12. Hamdan, M. and P.G. Righetti, 2005. Proteomics Today. Proteomics in Cancer Research. Chapter 2, John Wiley and Sons Publisher, New Jersey, pp: 69-126.
13. Ivancsits, S., E. Diem, O. Jahn and H.W. Rüdiger, 2003a. Age-related effects on induction of DNA strand breaks by intermittent exposure to electromagnetic fields. Mech. Ageing Dev., 124: 847-850.
14. Ivancsits, S., E. Diem, O. Jahn and H.W. Rudiger, 2003b. Intermittent extremely low frequency electromagnetic fields cause DNA damage in a dose-dependent way. Int. Arch. Occup. Environ. Health, 76: 431-436.
15. Li, H., Q. Zeng, Y. Weng, D. Lu, H. Jiang and Z. Xu, 2005. Effects of ELF magnetic fields on protein expression profile of human breast cancer cell MCF7. Sci. China C Life Sci., 48: 506-514.
16. Loo, C.K. and P.B. Mitchell, 2005. A review of the efficacy of Transcranial Magnetic Stimulation (TMS) treatment for depression and current and future strategies to optimize efficacy. J. Affective Disorders, 88: 255-267.
17. Löschinger, M., 1998. Stimulation of protein kinase A activity and induced terminal differentiation of human skin fibroblasts in culture by low-frequency electromagnetic fields. Toxicol. Lett., 96: 369-376.
18. Mairs, R., K. Hughes, S. Fitzsimmons, K. Prise, A. Livingstone, L. Wilson, N. Baig, A. Clark, A. Timpson, G. Patel, M. Folkard, W. Angerson and M. Boyd, 2007. Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro. Mutation Res., 626: 34-41.
19. Mantovani, A., 2005. Application of transcranial magnetic stimulation to therapy in psychiatry. Psychiatric Times, Vol. XXI, Issue 9.
20. McCann, J., F. Dietrich, C. Rafferty and A.O. Martin, 1993. A critical reviewof the genotoxic potential of electric and magnetic fields. Mutat. Res., 297: 61-95.
21. Michael, J., 2004. Crumpton, Are environmental electromagnetic fields genotoxic? DNA Repair, 3: 1385-1387.
22. Moscow, J.A. and K.H. Cowan, 1988. Multidrug resistance. J. Natl. Cancer Inst., 80: 14-20.
23. Moulder, J.E., 1998. Power-frequency fields and cancer. Crit. Rev. Biomed. Eng., 26: 1-116.
24. Narita, W., K. Hanakawa, T. Kasahara, T. Hisamitsu and K. Asano, 1997. Induction of apoptotic cell death in human leukemic cell line, HL-60, by extremely low frequency electric magnetic fields: Anal. Possible Mechanisms in vitro. In vivo, 11: 329-336.
25. Nooter, K. and G. Stoter, 1996. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract., 192: 768-780.
26. Rezaei Tavirani, M., A. Marashi, Z. Ghalanbor and M. Mostafavi, 2006. Proteomics. Chapter 2, Andisheh Zohour Publisher, Tehran, Iran, pp: 21-36.
27. Ryu, J.W., H.J. Kim, Y.S. Lee, N.H. Myong, C.H. Hwang G.S. Lee and H.C. Yom, 2003. The Proteomics Approach to Find Biomarkers in Gastric Cancer. J. Korean Med. Sci., 18: 505-509.
28. Saba, G., C.M. Verdon, K. Kalauo, J.F. Rocamora, G. Dumortier, R. Benadhira, L. Stamatiadis, E. Vicaut, H. Lipski and D. Januel, 2004. Transcrinial magnetic stimulation in treatment of schizophrenic symptoms: A double blind sham controlled study. J. Psychiat. Res.,
29. Saba, G., 2006. Transcrinial magnetic stimulation in treatment of schizophrenic symptoms: Adouble blind sham controlled study. J. Psychiatr. Res., 40: 147-152.
30. Schweigert, F.J. and J. Sehouli, 2005. Transthyretin, a biomarker for nutritional status and ovarian cancer. Cancer Res., 65:
31. Serot, J.M., D. Christmann, T. Dubost and M. Couturier, 1997. Cerebrospinal fluid transthyretin: Aging and late onset alzheimer's disease. J. Neurol. Neurosurg, Psychiat., 63: 506-508.
32. Sousa, J.C., I. Cardoso, F. Marques, M.J. Saraiva and J.A. Palha, 2007. Transthyretin and Alzheimer's disease: Where in the brain? Neurobiol. Aging, 28: 713-738.
33. Vijayalaxmi, V. and G. Obe, 2005. Controversial cytogenetic observations in mammalian somatic cells exposed to extremely low frequency electromagnetic radiation: A review and future research recommendations. Bioelectromagnetics, 26: 412-430.
34. Winker, R., S. Ivancsits, A. Pilger, F. Adlkofer and H.W. R̈udiger, 2005. Chromosomal damage in human diploid fibroblasts by intermittent exposure to extremely low-frequency electromagnetic fields. Mutat. Res., 585: 43-49.